CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,008 | -99.9% | 121,122 | -40.6% | 0.02% | -5.6% |
| Q2 2022 | $1,430,000 | +694.4% | 203,993 | +837.9% | 0.02% | +800.0% |
| Q1 2022 | $180,000 | -56.6% | 21,751 | -64.5% | 0.00% | -50.0% |
| Q4 2021 | $415,000 | +9.5% | 61,315 | -14.3% | 0.00% | -20.0% |
| Q3 2021 | $379,000 | +151.0% | 71,509 | +171.7% | 0.01% | +150.0% |
| Q2 2021 | $151,000 | +7.9% | 26,318 | -37.1% | 0.00% | +100.0% |
| Q4 2020 | $140,000 | +197.9% | 41,827 | +308.7% | 0.00% | 0.0% |
| Q2 2020 | $47,000 | – | 10,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |